In July 2025, the federal government is introducing a National Lung Cancer Screening Program (NLCSP) targeting the population most at risk, aiming for early detection of lung cancer. ELUCiD has positioned itself at the forefront of the clinical response to this program with the implementation of a...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2024 (2 years)
Address:
TECHNOLOGY PL; 203; MACQUARIE PARK, NEW SOUTH WALES 2113, AU
LOW
spending power